首页>
外国专利>
Lung cancer patient therapeutic agent and method for predicting the effectiveness of lung cancer patient treatment
Lung cancer patient therapeutic agent and method for predicting the effectiveness of lung cancer patient treatment
展开▼
机译：肺癌患者治疗剂和预测肺癌患者治疗效果的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided are a lung cancer therapeutic agent for treating a lung cancer patient, in particular, an NSCLC patient having resistance to EGFR-TKI, and a predictive test method for the effectiveness of the lung cancer patient treatment. As a result of earnest examination of therapeutic agents for lung cancer patients with an optimal combination of HDAC inhibitor and EGFR-TKI, `` If BIM in the sample derived from NSCLC patients resistant to EGFR-TKI is non-wild type, EGFR -TKI monotherapy is less effective, but it is effective for treatment of lung cancer patients combined with JNJ-26481585 and EGFR-TKI or lung cancer patients combined with CUDC-101 and EGFR-TKI The present invention has been completed.
展开▼
